Hematopoietic Cell Transplantation for Treatment of Patients With Primary Immunodeficiencies and Other Nonmalignant Inherited Disorders Using Low-dose TBI and Fludarabine With or Without Campath.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alemtuzumab; Ciclosporin; Fludarabine; Mycophenolate mofetil
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 17 Feb 2020 Biomarkers information updated
- 06 Mar 2013 New source identified and integrated (Vanderbilt-Ingram Cancer Center: VICCNCPED10101).
- 20 Oct 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2015 as reported by ClinicalTrials.gov.